Skip to main content

Advertisement

Log in

Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Hochman MJ, Martin DB (2021) Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL. Ann Hematol 100(2):579–580

    Article  Google Scholar 

  2. Vitale C, Ahn IE, Sivina M, Ferrajoli A, Wierda WG, Estrov Z, Konoplev SN, Jain N, O’Brien S, Farooqui M, Keating MJ, Wiestner A, Burger JA (2016) Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib. Haematologica 101(6):e254–e258

    Article  CAS  Google Scholar 

  3. Rider TG, Grace RJ, Newman JA (2016) Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia. Br J Haematol 173(2):326–327

    Article  Google Scholar 

  4. Suzuki T, Miyakoshi S, Nanba A, Uchiyama T, Kawamoto K, Aoki S (2018) A case of chronic lymphocytic leukemia complicated by autoimmune hemolytic anemia due to ibrutinib treatment. J Clin Exp Hematop 58(3):136–140

    Article  Google Scholar 

  5. Molica S, Polliack A (2016) Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy. Leuk Res 50:31–36

    Article  Google Scholar 

  6. Hampel PJ, Larson MC, Kabat B, Call TG, Ding W, Kenderian SS, Bowen D, Boysen J, Schwager SM, Leis JF, Chanan-Khan AA, Muchtar E, Hanson CA, Slager SL, Kay NE, Chaffee KG, Shanafelt TD, Parikh SA (2018) Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre. Br J Haematol 183(3):421–427

    Article  Google Scholar 

  7. St Bernard R, Hsia CC (2015) Safe utilization of ibrutinib with or without steroids in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Ann Hematol 94(12):2077–2079

    Article  Google Scholar 

  8. Goldschmidt N, Rund D (2017) Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib. Leuk Lymphoma 58(2):498–500

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Krečak.

Ethics declarations

Ethics approval

Patient provided consent for this publication. The General Hospital of Šibenik-Knin County, Croatia, does not require ethical approval for reporting individual case reports or case series.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krečak, I., Čengić, M., Skorić, I. et al. Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib. Ann Hematol 100, 2861–2862 (2021). https://doi.org/10.1007/s00277-021-04570-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-021-04570-4

Navigation